These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 16872912)

  • 1. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
    Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
    J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension in estrogen-deficient rats.
    Tofovic PS; Zhang X; Petrusevska G
    Prilozi; 2009 Jul; 30(1):25-44. PubMed ID: 19736529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats.
    Tofovic SP; Zhang X; Jackson EK; Zhu H; Petrusevska G
    Vascul Pharmacol; 2009; 51(2-3):190-7. PubMed ID: 19540933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic therapeutic effects of 2-methoxyestradiol with either sildenafil or bosentan on amelioration of monocrotaline-induced pulmonary hypertension and vascular remodeling.
    Tofovic SP; Jones TJ; Bilan VP; Jackson EK; Petrusevska G
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):475-83. PubMed ID: 20881615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent therapeutic effects of 2-Methoxyestradiol on Monocrotaline-Induced pulmonary hypertension and vascular remodelling.
    Tofovic SP; Jones T; Petrusevska G
    Prilozi; 2010; 31(1):279-95. PubMed ID: 20693947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of erectile function in monocrotaline-treated pulmonary hypertensive rats.
    Gur S; Kadowitz PJ; Thammasitboon S; Lasky JA; Hellstrom WJ
    J Androl; 2009; 30(5):495-504. PubMed ID: 19201699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Ethoxyestradiol is antimitogenic and attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling.
    Tofovic SP; Zhang X; Zhu H; Jackson EK; Rafikova O; Petrusevska G
    Vascul Pharmacol; 2008; 48(4-6):174-83. PubMed ID: 18373958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
    Jasmin JF; Mercier I; Dupuis J; Tanowitz HB; Lisanti MP
    Circulation; 2006 Aug; 114(9):912-20. PubMed ID: 16940204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension].
    Tabata T; Ono S; Song C; Noda M; Suzuki S; Tanita T; Fujimura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):160-6. PubMed ID: 9103852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.
    Zeng Z; Li Y; Jiang Z; Wang C; Li B; Jiang W
    Cardiovasc Ther; 2010; 28(1):23-9. PubMed ID: 20074256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension].
    Ono S; Tanita T; Hoshikawa Y; Song C; Maeda S; Tabata T; Noda M; Ueda S; Ashino Y; Fujimura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats.
    Wang Y; Zhang XH; Wang HL
    Can J Physiol Pharmacol; 2011 May; 89(5):345-54. PubMed ID: 21619414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats.
    Naito Y; Hosokawa M; Hao H; Sawada H; Hirotani S; Iwasaku T; Okuhara Y; Eguchi A; Hirota S; Ohyanagi M; Tsujino T; Masuyama T
    Biochem Biophys Res Commun; 2013 Jun; 436(2):145-51. PubMed ID: 23707944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.